# Thrombolysis in Myocardial Ischemia Trial (TIMI III)

> **NCT00000472** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Angina Pectoris
- Cardiovascular Diseases
- Coronary Disease
- Heart Diseases
- Myocardial Infarction
- Myocardial Ischemia

## Interventions

- **DRUG:** tissue plasminogen activator
- **DRUG:** heparin

## Key facts

- **NCT ID:** NCT00000472
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1989-04
- **Primary completion:** —
- **Final completion:** 1995-06
- **Target enrollment:** — (—)
- **Last updated:** 2016-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000472, "Thrombolysis in Myocardial Ischemia Trial (TIMI III)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00000472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*